Profiling the Skin Microbiome in Response to Altreno in Acne Patients
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The study objective is to characterize the shift in the diversity and abundance of the skin
microbial community at baseline and in response to Altreno monotherapy as compared to benzoyl
peroxide (BPO) 2.5% leave-on gel monotherapy in acne patients.